Average Co-Inventor Count = 7.34
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Array Biopharma Inc. (14 from 329 patents)
2. Genentech, Inc. (10 from 3,221 patents)
3. Cv Therapeutics, Inc. (8 from 105 patents)
4. The Penn State Research Foundation (2 from 1,217 patents)
5. Gilead Palo Alto, Inc. (2 from 15 patents)
6. Other (1 from 832,680 patents)
7. Gilead Sciences, Inc. (1 from 919 patents)
8. Covenentech, Inc. (1 from 1 patent)
9. Genertech, Inc. (1 from 1 patent)
28 patents:
1. 9409886 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
2. 9359340 - Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors
3. 9303040 - Substituted piperazines as AKT inhibitors
4. 8853199 - Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
5. 8853216 - Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor
6. 8846681 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
7. 8846683 - Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
8. 8835434 - Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
9. 8680114 - AKT protein kinase inhibitors
10. 8618097 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
11. 8377937 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
12. 8329701 - Dihydrofuro pyrimidines as AKT protein kinase inhibitors
13. 8324224 - [object Object]
14. 8063050 - Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
15. 8003651 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors